EZH2 and neoplasm: The tumor was diagnosed as b-HCA by standard immunostaining assays, which also showed expression of AR (androgen receptor) in the lesional cells, indicating receptor activation, but with no increase in EZH2 (Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit) protein expression.